Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 20.81.
Forward PE Ratio (20.81) = Close Price ($89.54) / Consensus Forward EPS ($4.30)
FORWARD PE RATIO
20.81
SECTOR MEDIAN · HEALTHCARE
20.29
median of 78 covered companies
CURRENT VS SECTOR MEDIAN
+2.59%
vs the sector median at left
Merit Medical Systems, Inc.
Market Cap
$5.35B
Forward PE Ratio
20.81
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Merit Medical Systems, Inc. (MMSI) | $5.35B | 20.81 |
| Doximity, Inc. (DOCS)vs › | $4.79B | 16.55 |
| Chemed Corporation (CHE)vs › | $6.80B | 20.38 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $3.17B | 61.33 |
| Oscar Health, Inc. (OSCR)vs › | $7.79B | 18.12 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 7.22 |
| Teladoc Health, Inc. (TDOC)vs › | $1.16B | N/A |
| Insulet Corp. (PODD)vs › | $9.93B | 22.05 |
| The Ensign Group, Inc. (ENSG)vs › | $10.11B | 22.26 |
Trailing P/E
37.0
reported TTM EPS
Forward P/E
20.8
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $4.30 implies +77.7% EPS growth vs the reported trailing $2.42.
At today's $89.54 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $4.30 | $4.27 – $4.31 | 7 | 20.8x |
| 2027-12-31 | $4.61 | $4.49 – $4.76 | 7 | 19.4x |
| 2028-12-31 | $4.96 | $4.74 – $5.11 | 4 | 18.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute